Search Within

Craig Moskowitz

  1. "2017"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (15)
Groups
  1. Department of Medicine (37)
  2. Hematologic Malignancies, Division of (37)
  3. Center for Hematologic Malignancies (26)
  4. Lymphoma (25)
  5. Survivorship Research (23)
  6. Epidemiology and Biostatistics (17)

More Groups

People
  1. Matthew Matasar (20)
  2. Alison Moskowitz (17)
  3. Anas Younes (15)
  4. Andrew Zelenetz (15)
  5. David Straus (15)
  6. Paul Hamlin (14)

More People

Years
  1. 2017 (37)
Publications
  1. Hematological Oncology (11)
  2. Blood (9)
  3. Annals of Oncology (2)
  4. Biology of Blood and Marrow Transplantation (2)
  5. Journal of Clinical Oncology (2)
  6. Biomarker Research (1)

More Publications

Publishers
  1. Wiley Blackwell (11)
  2. American Society of Hematology (9)
  3. Elsevier Inc. (4)
  4. Oxford University Press (3)
  5. American Association for Cancer Research (2)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition
    Journal Article

    Mathias, M. D.; Ortiz, M. V.; Magnan, H.; Ambati, S. R.; Slotkin, E. K.; Chou, A. J.; Walsh, M. F.; Offit, K.; Moskowitz, C.; Kentsis, A.; more...
    Biomarker Research (2017)

    Fulltext@MSK | Save
  • Highlights in lymphoma from the 2017 ASCO meeting and the 14th ICML: Commentary
    Journal Article

    Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2017)

    Fulltext@MSK | Save
  • Patient-reported outcomes in patients with classical Hodgkin lymphoma treated with pembrolizumab monotherapy, results of a phase 2 study
    Meeting Abstract

    von Tresckow, B.; Fanale, M. A.; Ardeshna, K. M.; Chen, R. W.; Meissner, J.; Morschhauser, F.; Moskowitz, C. H.; Zinzani, P. L.; Giezek, H.; Balakumaran, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Pembrolizumab antitumor activity in relapsed/refractory classical Hodgkin lymphoma in Keynote-087: Revised Response Criteria for Malignant Lymphoma 2007 criteria versus Lugano 2014 classification
    Meeting Abstract

    Moskowitz, C. H.; Chen, R. W.; Armand, P.; Zinzani, P. L.; Vassilakopoulos, T. P.; Goldmacher, G. V.; Lin, J.; Nahar, A.; Balakumaran, A.; Salles, G.
    Blood (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Genomic characteristics clinical phenotype and disease course of TP53 mutated diffuse large B cell lymphoma at diagnosis and relapse
    Meeting Abstract

    Joffe, E.; Batlevi, C. L.; Intlekofer, A. M.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Noy, A.; Straus, D. J.; Portlock, C. S.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
    Meeting Abstract

    Herrera, A. F.; Moskowitz, A. J.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; LaCasce, A. S.; Ansell, S. M.; Moskowitz, C. H.; Fenton, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Active surveillance for newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma
    Meeting Abstract

    Borchmann, S.; Joffe, E.; Moskowitz, C. H.; Zelenetz, A. D.; Noy, A.; Portlock, C. S.; Gerecitano, J. F.; Batlevi, C.; Caron, P.; Drullinsky, P.; more...
    Blood (2017)

    Fulltext@MSK | Save